- Home
- GBLI vs EBS Comparison
GBLI vs EBS Comparison
Compare GBLI & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GBLI
- EBS
- Stock Information
- Founded
- GBLI 2016
- EBS 1998
- Country
- GBLI United States
- EBS United States
- Employees
- GBLI N/A
- EBS N/A
- Industry
- GBLI Property-Casualty Insurers
- EBS Biotechnology: Pharmaceutical Preparations
- Sector
- GBLI Finance
- EBS Health Care
- Exchange
- GBLI Nasdaq
- EBS Nasdaq
- Market Cap
- GBLI 476.1M
- EBS 393.9M
- IPO Year
- GBLI 2003
- EBS 2006
- Fundamental
- Price
- GBLI $34.80
- EBS $4.88
- Analyst Decision
- GBLI
- EBS Strong Buy
- Analyst Count
- GBLI 0
- EBS 3
- Target Price
- GBLI N/A
- EBS $14.33
- AVG Volume (30 Days)
- GBLI 5.4K
- EBS 1.4M
- Earning Date
- GBLI 03-11-2025
- EBS 03-03-2025
- Dividend Yield
- GBLI 4.08%
- EBS N/A
- EPS Growth
- GBLI 70.49
- EBS N/A
- EPS
- GBLI 3.12
- EBS N/A
- Revenue
- GBLI $441,087,000.00
- EBS $1,043,600,000.00
- Revenue This Year
- GBLI $12.07
- EBS $9.43
- Revenue Next Year
- GBLI N/A
- EBS N/A
- P/E Ratio
- GBLI $11.01
- EBS N/A
- Revenue Growth
- GBLI N/A
- EBS N/A
- 52 Week Low
- GBLI $29.55
- EBS $1.82
- 52 Week High
- GBLI $37.00
- EBS $15.10
- Technical
- Relative Strength Index (RSI)
- GBLI 44.40
- EBS 32.69
- Support Level
- GBLI $34.20
- EBS $4.53
- Resistance Level
- GBLI $36.61
- EBS $5.93
- Average True Range (ATR)
- GBLI 0.74
- EBS 0.40
- MACD
- GBLI -0.16
- EBS 0.04
- Stochastic Oscillator
- GBLI 21.43
- EBS 29.06
About GBLI Global Indemnity Group LLC (DE)
Global Indemnity Group LLC provides both admitted and non-admitted specialty property and casualty insurance coverages and individual policyholder coverages in the United States, as well as reinsurance worldwide. The company's three primary segments are Commercial Specialty, Reinsurance operations, and Exited Lines. The majority of its revenue is from the Commercial Specialty segment. Geographically, the majority is from California.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.